Literature DB >> 17289451

Posttranslational modifications in human plasma MBL and human recombinant MBL.

Pia Hønnerup Jensen1, Inga Laursen, Finn Matthiesen, Peter Højrup.   

Abstract

Mannan-binding lectin (MBL) is a complex serum protein that plays an important role in innate immunity. In addition to assuming several different oligomeric forms, the polypeptide itself is highly heterogeneous. This heterogeneity is due to post-translational modifications, which help to stabilize the intact protein in its active conformation. For the first time, positions and occupation frequency of partial hydroxylations and partial glycosylations are reported in MBL. Hydroxylation and glycosylation patterns of both recombinant and plasma derived MBL were determined, using a combination of mass spectrometry on reduced MBL and on enzyme cleaved MBL. Variations in the degree of hydroxylation and glycosylation seem to be an indigenous characteristic of collectins. In addition to these already known modifications, a new post-translational modification was identified. Cys(216) (and occasionally also Cys(202)) was modified in trace amounts to dehydroalanine, as detected by a 34 Da mass loss. This impairs the formation of a disulphide bond in the carbohydrate recognition domain. The dehydroalanine was identified in similar small amounts in both recombinant and plasma-derived MBL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289451     DOI: 10.1016/j.bbapap.2006.12.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Mannose Binding Lectin Is Hydroxylated by Collagen Prolyl-4-hydroxylase and Inhibited by Some PHD Inhibitors.

Authors:  Vijesh J Bhute; James Harte; Jack W Houghton; Patrick H Maxwell
Journal:  Kidney360       Date:  2020-04-03

2.  Lysyl hydroxylase 3 modifies lysine residues to facilitate oligomerization of mannan-binding lectin.

Authors:  Maija Risteli; Heli Ruotsalainen; Ulrich Bergmann; Umakhanth Venkatraman Girija; Russell Wallis; Raili Myllylä
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

Review 3.  The lectin pathway of complement and rheumatic heart disease.

Authors:  Marcia Holsbach Beltrame; Sandra Jeremias Catarino; Isabela Goeldner; Angelica Beate Winter Boldt; Iara José de Messias-Reason
Journal:  Front Pediatr       Date:  2015-01-21       Impact factor: 3.418

4.  Substitution of Mannan-Binding Lectin (MBL)-Deficient Serum With Recombinant MBL Results in the Formation of New MBL/MBL-Associated Serine Protease Complexes.

Authors:  Mischa P Keizer; Angela Kamp; Gerard van Mierlo; Taco W Kuijpers; Diana Wouters
Journal:  Front Immunol       Date:  2018-06-27       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.